Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast taking place at the San Mateo Event Center, California, on Wednesday 10th – Thursday 11th March 2016.
Transdermal systems are pharmaceutical patches that transport the active substances directly into the bloodstream through the skin – often with fewer side effects than tablets.
World leading pioneer on drug discovery through open innovation, joins the stem cell disease model specialists.
The stem cell disease model specialists also showcase expanded range of primary and iPSC-derived cells for drug discovery.
Scott Heffern: Our wheelhouse and blending is IBC blending, containment blending, many different words for it. We make many different types of blenders. We make V-blenders, double cone blenders, kind of the old standards, check blenders.
With temperatures regularly reaching -70°C, the coldest place on earth is unsurprisingly the Antarctic. Source BioScience is now able to replicate these bone-chilling temperatures in an innovative, efficient storage solution.
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer (CSO). Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. A biotech entrepreneur with an extensive list of peer-reviewed publications, she is a well-established and internationally-recognised leader in the creation of disease models for drug discovery.
Accutest Research Laboratories, a leading independent and internationally accredited Contract Research Organization (CRO), has formed a strategic partnership with Fox Chase Cancer Center - Temple Health for joint work on clinical trials.
Bob Luebbe: Many years ago a system was one or two pieces of equipment put together. What we do now are really bring a whole lot of different pieces together. It used to be just a bin and a blender or a bin and a discharge station, a bin and a fill station. Now it's filling, it's blending, it's discharging, its containment.
Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, and Axol Bioscience Ltd (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems, announce they have formed a strategic partnership for the delivery of off-the-shelf and on-demand genomically modified and differentiated iPS cells.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.